CONMED logo

CONMEDNYSE: CNMD

Profile

Sector:

Healthcare

Country:

United States

IPO:

23 July 1987

Next earnings report:

31 January 2025

Last dividends:

16 September 2024

Next dividends:

N/A
$2.19 B
-51%vs. 3y high
82%vs. sector
-78%vs. 3y high
28%vs. sector
-59%vs. 3y high
63%vs. sector
-61%vs. 3y high
35%vs. sector

Price

after hours | 15 min ago
$70.77-$2.07(-2.84%)
$316.70 M$340.99 M
$316.70 M$48.98 M

Analysts recommendations

Institutional Ownership

CNMD Latest News

CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
businesswire.com18 November 2024 Sentiment: -

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat J. Beyer, Chief Operating Officer, will participate in a fireside chat at the Piper Sandler Healthcare Conference at 12:30 p.m. ET on Tuesday, December 3, 2024. A live video webcast of the fireside chat will be accessible through the “Investors” section of the Company's website at.

Here's Why Conmed (CNMD) is a Strong Growth Stock
zacks.com08 November 2024 Sentiment: POSITIVE

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

CONMED Beats on Q3 Earnings, Misses on Sales, Lowers '24 Sales View
zacks.com31 October 2024 Sentiment: POSITIVE

CNMD's Q3 earnings beat estimates on the back of higher revenues and lower costs and expenses.

Conmed (CNMD) Reports Q3 Earnings: What Key Metrics Have to Say
zacks.com30 October 2024 Sentiment: POSITIVE

The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Conmed (CNMD) Earnings Expected to Grow: Should You Buy?
zacks.com23 October 2024 Sentiment: POSITIVE

Conmed (CNMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Conmed (CNMD) Beat Estimates Again in Its Next Earnings Report?
zacks.com14 October 2024 Sentiment: POSITIVE

Conmed (CNMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why Conmed (CNMD) is a Strong Growth Stock
zacks.com07 October 2024 Sentiment: POSITIVE

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why You Should Retain CONMED Stock in Your Portfolio
zacks.com07 October 2024 Sentiment: POSITIVE

CNMD is poised for growth with strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.

Carpal Tunnel Release Systems Market Forecast Report 2024-2030, Featuring Profiles of Arthrex, Conmed, Innomed, MicroAire Surgical Instruments, Resurgens Orthopaedics, S2S Surgical and Trice Medical
globenewswire.com12 September 2024 Sentiment: POSITIVE

Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "Carpal Tunnel Release Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Carpal Tunnel Release Systems was estimated at US$604.4 Million in 2023, and is projected to reach US$809.7 Million by 2030, growing at a CAGR of 4.3% from 2023 to 2030. The growth in the carpal tunnel release systems market is driven by several factors, including technological advancements, an increase in the prevalence of conditions requiring such interventions, and heightened patient preference for minimally invasive procedures. The continuous development of new technologies such as enhanced endoscopic equipment and improved surgical techniques contributes significantly to the efficacy and safety of carpal tunnel surgeries, appealing to both surgeons and patients.

CONMED (CNMD) Q2 Earnings Beat, Sales Rise Y/Y, '24 View Cut
zacks.com01 August 2024 Sentiment: POSITIVE

CONMED (CNMD) beats second-quarter earnings estimates on the back of higher revenues and lower costs and expenses. However, the result reflects the continued impact of supply chain issues.

  • 1(current)
  • 2
  • 3

What type of business is CONMED?

CONMED Corporation is a global company in the field of medical technology, specializing in the development, manufacture, and sale of surgical equipment. It was founded in 1970. The headquarters are located in Largo, Florida (USA). CONMED Corporation produces two product lines: Orthopedic surgery - products for joint trauma recovery, implants, electrically powered surgical instruments, tissue recovery kits, as well as related disposable items (razor blades, drills, and pump tubes). General surgery - a wide range of products in the field of surgical, endoscopic technologies, and intensive care: devices for hemostasis, treatment of biliary structures, and cardiac monitoring, including electrodes for ECG and EEG, defibrillation pads, graspers, scissors, dissectors, and others used in minimally invasive surgery.

What sector is CONMED in?

CONMED is in the Healthcare sector

What industry is CONMED in?

CONMED is in the Medical Devices industry

What country is CONMED from?

CONMED is headquartered in United States

When did CONMED go public?

CONMED initial public offering (IPO) was on 23 July 1987

What is CONMED website?

https://www.conmed.com

Is CONMED in the S&P 500?

No, CONMED is not included in the S&P 500 index

Is CONMED in the NASDAQ 100?

No, CONMED is not included in the NASDAQ 100 index

Is CONMED in the Dow Jones?

No, CONMED is not included in the Dow Jones index

When was CONMED the previous earnings report?

No data

When does CONMED earnings report?

The next expected earnings date for CONMED is 31 January 2025